Literature DB >> 6355525

The value of serum thyroglobulin measurement in clinical practice.

S Refetoff, E G Lever.   

Abstract

Thyroglobulin (TG) is a normal constituent of serum detectable by radioimmunoassay in 75% to 90% of healthy adults. Levels are altered in a number of physiological and pathological conditions. Although the indications for serum TG measurements have not been clearly established, it is simple, inexpensive, and presents no risk of radiation exposure. Problems include variable sensitivity and reproducibility of assays, interference by TG autoantibodies, and changes induced by certain diagnostic or therapeutic interventions. Serum TG measurements is primarily used as a tumor marker in thyroid carcinoma. Values are almost invariably high with disseminated metastases. After total ablation of thyroid tissue, serum TG determination is useful in separating patients in remission from those with residual metastatic disease. Serial measurements in the same patients are useful in monitoring the effect of treatment of nonfunctioning thyroid metastases. It is of no proved value in the initial diagnosis of thyroid carcinoma. Controversy still exists regarding the advantages of measuring TG during hormonal therapy. The assay may aid in the diagnosis of thyrotoxicosis factitia, painless subacute thyroiditis, and neonatal hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6355525

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  10 in total

Review 1.  Endemic goiter and endemic thyroid disorders.

Authors:  E Gaitan; N C Nelson; G V Poole
Journal:  World J Surg       Date:  1991 Mar-Apr       Impact factor: 3.352

2.  Serum thyroglobulin concentration in nontoxic goiter and response to surgery with special reference to risk of goiter relapse.

Authors:  U Feldt-Rasmussen; M Blichert-Toft; J Date; V Haas
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

Review 3.  Serum thyroglobulin (Tg) in presence of thyroglobulin autoantibodies (TgAb). Clinical and methodological relevance of the interaction between Tg and TgAb in vitro and in vivo.

Authors:  U Feldt-Rasmussen; A K Rasmussen
Journal:  J Endocrinol Invest       Date:  1985-12       Impact factor: 4.256

4.  Iodized oil treatment for endemic goiter does not induce the surge of positive serum concentrations of anti-thyroglobulin or anti-microsomal autoantibodies.

Authors:  M Knobel; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

5.  A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients.

Authors:  M Schlumberger; P Fragu; P Gardet; J Lumbroso; D Violot; C Parmentier
Journal:  Eur J Nucl Med       Date:  1991

6.  [Thyroglobulin content of the blood in cases of hanging].

Authors:  E Müller; C Erfurt; W G Franke
Journal:  Z Rechtsmed       Date:  1990

7.  European interlaboratory comparison of serum thyroglobulin measurement.

Authors:  U Feldt-Rasmussen; M Schlumberger
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

8.  Predictive value of serum thyroglobulin in treated patients with differentiated thyroid carcinoma.

Authors:  D C Stephen; M S Seshadri; R Oommen; A Nair; S Swaminathan; A S Kanagasabapathy
Journal:  Indian J Clin Biochem       Date:  1999-01

9.  Short-term beta-adrenergic blockade decreases serum thyroglobulin in hyper- and euthyroid patients.

Authors:  H Perrild; U Feldt-Rasmussen; L Kayser; J Mølholm Hansen
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

10.  The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignature.

Authors:  Raymon H Grogan; Elliot J Mitmaker; Orlo H Clark
Journal:  Cancers (Basel)       Date:  2010-05-20       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.